David Richard

David Richard is an experienced medicinal chemist currently serving as Director of Medicinal Chemistry at Foghorn Therapeutics, Inc. since February 2022, following a tenure as Principal Scientist in the same company. Prior to this, David held a role as Principal Scientist and Chemistry Team Lead at FORMA Therapeutics and served as Director of Drug Discovery and Development at Eutropics Pharmaceuticals, leading projects focused on small molecules for oncology. David's experience includes working as a Principal Scientist at Pfizer, contributing to inflammation and immunology research, and serving as a Senior Research Scientist at Wyeth Research. Academic credentials include a PhD in Chemistry from the University of Pennsylvania and a BS in Chemistry from Bates College, along with postdoctoral research at Princeton University.